Summary Curemark LLC (Curemark) is a biopharmaceutical company that develops novel therapies for the treatment of neurological disorders.The company’s pipeline products include CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drug candidates.
Its drug candidate CM-AT is a clinical trial for autism, ADHD, and multiple preclinical programs.Curemark’s pipeline also comprises clinical-stage and preclinical programs for treating ADHD, Parkinson’s, schizophrenia and addiction.
The company partners with other biopharmaceutical and pharmaceutical companies for its drug development activities. Curemark is headquartered in Rye, New York, the US.
Curemark LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The IR spectroscopy market is expected to grow at a CAGR of 4.1% from USD 1.0 billion in 2020 to USD 1.3 billion. Increasing demand of spectroscopy products in the healthcare & pharmaceuticals industry and food & beverages industry will drive the market. IR spectroscopy market for far-infrared technology is expected to grow...
United States Active Pharmaceutical Ingredient Market, By Method of Synthesis (Biological v/s. Synthetic), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Disease, Anti-diabetic, Oncology, Neurological Disorders, Musculoskeletal,...
Iceland Pharmaceutical Market Report Overview Iceland Pharmaceutical market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Iceland Pharmaceutical market types and applications. It is a focused study on Iceland Pharmaceutical market space...
Pharmaceutical Membrane Filtration Market Report Overview Pharmaceutical Membrane Filtration market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pharmaceutical Membrane Filtration market types and applications. It is a focused study on...
400 pages •
By The Business Research Company
• Feb 2021
Major companies in the pharmaceutical drug market include Novartis AG; Sanofi S.A.; Pfizer Inc.; Gilead Sciences, Inc. and Johnson & Johnson. The global pharmaceutical drugs market is expected to grow from $975.04 billion in 2020 to $981.73 billion in 2021 at a compound annual growth rate (CAGR) of 0.7%. The growth is mainly due to...
The nucleotides market is expected to grow at a CAGR of over 8% during the forecast period. The major factor driving the market studied is the growing demand for nucleotides from pharmaceuticals and Increased Demand due to the COVID-19 Outbreak. On the flip side, the high manufacturing cost of nucleotides are hindering the growth of the market. -...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
120 pages •
By Infiniti Research Limited
• Jan 2021
Global Lactase Enzyme Market 2021-2025
The analyst has been monitoring the lactase enzyme market and it is poised to grow by $ 131.55 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period. Our report on lactase enzyme market provides a holistic analysis, market size and forecast, trends, growth drivers,...
Global Biochip Market By Type (DNA Chips, Lab-On-a-Chips & Protein Chips), By Technology (Microarray v/s Microfluidics), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research...
The Quantum Computing market is expected to grow from USD 472 million in 2021 to USD 1,765 million by 2026, at a CAGR of 30.2%. The early adoption of quantum computing in the banking and finance sector is expected to fuel the growth of the market globally. Other key factors contributing to the growth of the quantum computing market include...
Computer
Artificial Intelligence
Cloud Computing
Pharmaceutical
Energy
Healthcare
Application
World
North America
Europe
APAC
Gross Domestic Product
Energy Consumption
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.